These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

499 related items for PubMed ID: 35280677

  • 1. Berberine ameliorates DSS-induced intestinal mucosal barrier dysfunction through microbiota-dependence and Wnt/β-catenin pathway.
    Dong Y, Fan H, Zhang Z, Jiang F, Li M, Zhou H, Guo W, Zhang Z, Kang Z, Gui Y, Shou Z, Li J, Zhu R, Fu Y, Sarapultsev A, Wang H, Luo S, Zhang G, Hu D.
    Int J Biol Sci; 2022; 18(4):1381-1397. PubMed ID: 35280677
    [Abstract] [Full Text] [Related]

  • 2. Berberine Depresses Inflammation and Adjusts Smooth Muscle to Ameliorate Ulcerative Colitis of Cats by Regulating Gut Microbiota.
    Li X, Xu S, Zhang Y, Li K, Gao XJ, Guo MY.
    Microbiol Spectr; 2022 Dec 21; 10(6):e0320722. PubMed ID: 36287004
    [Abstract] [Full Text] [Related]

  • 3. Oxyberberine, a novel gut microbiota-mediated metabolite of berberine, possesses superior anti-colitis effect: Impact on intestinal epithelial barrier, gut microbiota profile and TLR4-MyD88-NF-κB pathway.
    Li C, Ai G, Wang Y, Lu Q, Luo C, Tan L, Lin G, Liu Y, Li Y, Zeng H, Chen J, Lin Z, Xian Y, Huang X, Xie J, Su Z.
    Pharmacol Res; 2020 Feb 21; 152():104603. PubMed ID: 31863867
    [Abstract] [Full Text] [Related]

  • 4. Integration of microbiome, metabolomics and transcriptome for in-depth understanding of berberine attenuates AOM/DSS-induced colitis-associated colorectal cancer.
    Wang M, Ma Y, Yu G, Zeng B, Yang W, Huang C, Dong Y, Tang B, Wu Z.
    Biomed Pharmacother; 2024 Oct 21; 179():117292. PubMed ID: 39151314
    [Abstract] [Full Text] [Related]

  • 5. Berberrubine attenuates mucosal lesions and inflammation in dextran sodium sulfate-induced colitis in mice.
    Yu XT, Xu YF, Huang YF, Qu C, Xu LQ, Su ZR, Zeng HF, Zheng L, Yi TG, Li HL, Chen JP, Zhang XJ.
    PLoS One; 2018 Oct 21; 13(3):e0194069. PubMed ID: 29538417
    [Abstract] [Full Text] [Related]

  • 6. Pre-Administration of Berberine Exerts Chemopreventive Effects in AOM/DSS-Induced Colitis-Associated Carcinogenesis Mice via Modulating Inflammation and Intestinal Microbiota.
    Deng J, Zhao L, Yuan X, Li Y, Shi J, Zhang H, Zhao Y, Han L, Wang H, Yan Y, Zhao H, Wang H, Zou F.
    Nutrients; 2022 Feb 09; 14(4):. PubMed ID: 35215376
    [Abstract] [Full Text] [Related]

  • 7.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 10.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 11. Berberine improves colitis by triggering AhR activation by microbial tryptophan catabolites.
    Jing W, Dong S, Luo X, Liu J, Wei B, Du W, Yang L, Luo H, Wang Y, Wang S, Lu H.
    Pharmacol Res; 2021 Feb 09; 164():105358. PubMed ID: 33285228
    [Abstract] [Full Text] [Related]

  • 12.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 13. Huangqin decoction ameliorates DSS-induced ulcerative colitis: Role of gut microbiota and amino acid metabolism, mTOR pathway and intestinal epithelial barrier.
    Li MX, Li MY, Lei JX, Wu YZ, Li ZH, Chen LM, Zhou CL, Su JY, Huang GX, Huang XQ, Zheng XB.
    Phytomedicine; 2022 Jun 09; 100():154052. PubMed ID: 35344714
    [Abstract] [Full Text] [Related]

  • 14. Berberine represses Wnt/β-catenin pathway activation via modulating the microRNA-103a-3p/Bromodomain-containing protein 4 axis, thereby refraining pyroptosis and reducing the intestinal mucosal barrier defect induced via colitis.
    Zhao X, Cui D, Yuan W, Chen C, Liu Q.
    Bioengineered; 2022 Mar 09; 13(3):7392-7409. PubMed ID: 35259053
    [Abstract] [Full Text] [Related]

  • 15.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 16. Berberine improves DSS-induced colitis in mice by modulating the fecal-bacteria-related bile acid metabolism.
    Sun X, Zhang Y, Cheng G, Zhu T, Zhang Z, Xiong L, Hu H, Liu H.
    Biomed Pharmacother; 2023 Nov 09; 167():115430. PubMed ID: 37683590
    [Abstract] [Full Text] [Related]

  • 17. Berberine regulates intestinal microbiome and metabolism homeostasis to treat ulcerative colitis.
    Yang T, Qin N, Liu F, Zhao Y, Liu W, Fan D.
    Life Sci; 2024 Feb 01; 338():122385. PubMed ID: 38184271
    [Abstract] [Full Text] [Related]

  • 18.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 19.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 20.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 25.